CLXT Calyxt Inc

Price (delayed)

$0.2651

Market cap

$12.4M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.56

Enterprise value

$14.48M

Calyxt, based in Roseville, Minnesota, is a technology company with a mission to deliver plant-based innovations for a better world. Founded in 2010, Calyxt uses its proprietary TALEN® gene editing ...

Highlights
The gross margin has soared by 79% YoY
CLXT's EPS is up by 47% year-on-year and by 13% since the previous quarter
The gross profit has dropped by 160% since the previous quarter but it has soared by 94% year-on-year
The quick ratio has grown by 41% from the previous quarter but it has contracted by 14% YoY
The company's revenue has shrunk by 72% YoY and by 55% QoQ
The equity has declined by 37% year-on-year and by 8% since the previous quarter

Key stats

What are the main financial stats of CLXT
Market
Shares outstanding
46.79M
Market cap
$12.4M
Enterprise value
$14.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.82
Price to sales (P/S)
1.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.48
Earnings
Revenue
$9.78M
EBIT
-$21.72M
EBITDA
-$19.8M
Free cash flow
-$20.32M
Per share
EPS
-$0.56
Free cash flow per share
-$0.44
Book value per share
$0.32
Revenue per share
$0.21
TBVPS
$0.69
Balance sheet
Total assets
$32.02M
Total liabilities
$18.26M
Debt
$13.94M
Equity
$13.76M
Working capital
$8.36M
Liquidity
Debt to equity
1.01
Current ratio
2.86
Quick ratio
2.64
Net debt/EBITDA
-0.1
Margins
EBITDA margin
-202.5%
Gross margin
-5.2%
Net margin
-229.8%
Operating margin
-271.2%
Efficiency
Return on assets
-61.1%
Return on equity
-153.3%
Return on invested capital
-67.5%
Return on capital employed
-79%
Return on sales
-222.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CLXT stock price

How has the Calyxt stock price performed over time
Intraday
-3.98%
1 week
-2.79%
1 month
29.32%
1 year
-91.94%
YTD
-87.55%
QTD
9.77%

Financial performance

How have Calyxt's revenue and profit performed over time
Revenue
$9.78M
Gross profit
-$507,000
Operating income
-$26.52M
Net income
-$22.47M
Gross margin
-5.2%
Net margin
-229.8%
The gross profit has dropped by 160% since the previous quarter but it has soared by 94% year-on-year
The company's operating margin has shrunk by 154% YoY and by 128% QoQ
CLXT's net margin has plunged by 116% YoY and by 100% from the previous quarter
The gross margin has soared by 79% YoY

Growth

What is Calyxt's growth rate over time

Valuation

What is Calyxt stock price valuation
P/E
N/A
P/B
0.82
P/S
1.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.48
CLXT's EPS is up by 47% year-on-year and by 13% since the previous quarter
The P/B is 84% below the 5-year quarterly average of 5.4 and 80% below the last 4 quarters average of 4.4
The equity has declined by 37% year-on-year and by 8% since the previous quarter
The stock's price to sales (P/S) is 100% less than its 5-year quarterly average of 476.1 and 45% less than its last 4 quarters average of 2.4
The company's revenue has shrunk by 72% YoY and by 55% QoQ

Efficiency

How efficient is Calyxt business performance
CLXT's return on sales has dropped by 117% year-on-year and by 103% since the previous quarter
The ROE has contracted by 21% YoY and by 3.2% from the previous quarter
The ROA has grown by 8% YoY

Dividends

What is CLXT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLXT.

Financial health

How did Calyxt financials performed over time
The total assets is 75% more than the total liabilities
The current ratio is up by 44% from the previous quarter but it is down by 18% YoY
The quick ratio has grown by 41% from the previous quarter but it has contracted by 14% YoY
The equity has declined by 37% year-on-year and by 8% since the previous quarter
CLXT's debt to equity is up by 23% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.